OLD National Bancorp IN Sells 609 Shares of Cardinal Health, Inc. (NYSE:CAH)

OLD National Bancorp IN lowered its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 5.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,401 shares of the company’s stock after selling 609 shares during the period. OLD National Bancorp IN’s holdings in Cardinal Health were worth $1,121,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. Clearstead Trust LLC bought a new stake in shares of Cardinal Health in the 4th quarter worth $25,000. Raleigh Capital Management Inc. lifted its stake in Cardinal Health by 4,466.7% during the 4th quarter. Raleigh Capital Management Inc. now owns 274 shares of the company’s stock valued at $28,000 after acquiring an additional 268 shares during the period. YHB Investment Advisors Inc. purchased a new stake in shares of Cardinal Health during the 1st quarter valued at about $32,000. LRI Investments LLC bought a new stake in shares of Cardinal Health in the first quarter worth approximately $32,000. Finally, Hexagon Capital Partners LLC raised its holdings in shares of Cardinal Health by 53.6% during the fourth quarter. Hexagon Capital Partners LLC now owns 338 shares of the company’s stock valued at $34,000 after purchasing an additional 118 shares during the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Performance

Shares of Cardinal Health stock traded up $1.76 during trading hours on Friday, hitting $100.68. The company’s stock had a trading volume of 1,193,037 shares, compared to its average volume of 2,138,906. Cardinal Health, Inc. has a 12-month low of $85.11 and a 12-month high of $116.04. The business has a 50 day moving average price of $98.70 and a two-hundred day moving average price of $103.23. The company has a market cap of $24.52 billion, a PE ratio of 44.75, a PEG ratio of 1.14 and a beta of 0.61.

Analysts Set New Price Targets

A number of equities research analysts have commented on CAH shares. StockNews.com downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Thursday. Citigroup reduced their price objective on Cardinal Health from $115.00 to $107.00 and set a “neutral” rating for the company in a research report on Friday, July 19th. Robert W. Baird raised their target price on Cardinal Health from $129.00 to $130.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 9th. Wells Fargo & Company reduced their price target on shares of Cardinal Health from $96.00 to $94.00 and set an “underweight” rating for the company in a research report on Monday, April 29th. Finally, Evercore ISI dropped their price objective on shares of Cardinal Health from $115.00 to $105.00 and set an “in-line” rating on the stock in a report on Tuesday, July 9th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and eight have issued a buy rating to the company’s stock. According to data from MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average price target of $109.67.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.